Overall, the identification of NEAT1/miR-483/STAT3 axis contributed to the elucidation of the regulatory network involved in the progression of osteosarcoma and provided insights into the prognosis and development of targeted therapy for osteosarcoma in the future. This evidence concerns the gene STAT3 and osteosarcoma.